Oppenheimer & Co’s Amgen AMGN Stock Holding History

Oppenheimer & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.6M	Buy	123,217 +3,376	+3%	+$1.16M	0.48%	37
2026 Q1	$42.2M	Buy	+119,841	New	+$42.7M	0.51%	34
2025 Q4	–	Sell	-113,123	Closed	-$31.9M	–	1555
2025 Q3	$31.9M	Buy	113,123 +2,111	+2%	+$612K	0.39%	35
2025 Q2	$31M	Buy	111,012 +1,179	+1%	+$334K	0.41%	32
2025 Q1	$34.2M	Sell	109,833 -1,335	-1%	-$394K	0.52%	26
2024 Q4	$29M	Sell	111,168 -11,384	-9%	-$3.38M	0.43%	32
2024 Q3	$39.5M	Sell	122,552 -1,086	-0.9%	-$355K	0.6%	19
2024 Q2	$38.6M	Buy	123,638 +2,483	+2%	+$729K	0.61%	19
2024 Q1	$34.4M	Buy	121,155 +8,874	+8%	+$2.6M	0.57%	21
2023 Q4	$32.3M	Buy	112,281 +3,413	+3%	+$930K	0.59%	18
2023 Q3	$29.3M	Buy	108,868 +2,651	+2%	+$662K	0.6%	20
2023 Q2	$23.6M	Buy	106,217 +1,763	+2%	+$409K	0.47%	33
2023 Q1	$25.3M	Buy	104,454 +16,848	+19%	+$4.14M	0.54%	25
2022 Q4	$23M	Sell	87,606 -6,259	-7%	-$1.68M	0.52%	29
2022 Q3	$21.2M	Buy	93,865 +1,370	+1%	+$332K	0.49%	29
2022 Q2	$22.5M	Sell	92,495 -2,793	-3%	-$684K	0.48%	32
2022 Q1	$23M	Sell	95,288 -2,143	-2%	-$492K	0.42%	39
2021 Q4	$21.9M	Buy	97,431 +4,753	+5%	+$1M	0.38%	46
2021 Q3	$19.7M	Sell	92,678 -1,301	-1%	-$299K	0.37%	50
2021 Q2	$22.9M	Buy	93,979 +1,457	+2%	+$358K	0.41%	36
2021 Q1	$23M	Buy	92,522 +9,879	+12%	+$2.36M	0.46%	31
2020 Q4	$19M	Sell	82,643 -779	-0.9%	-$180K	0.4%	50
2020 Q3	$21.2M	Sell	83,422 -13,037	-14%	-$3.23M	0.53%	36
2020 Q2	$22.8M	Sell	96,459 -17,306	-15%	-$3.95M	0.59%	29
2020 Q1	$23.1M	Buy	113,765 +3,599	+3%	+$786K	0.7%	23
2019 Q4	$26.6M	Sell	110,166 -1,695	-2%	-$374K	0.66%	25
2019 Q3	$21.6M	Buy	111,861 +628	+0.6%	+$121K	0.59%	32
2019 Q2	$20.5M	Sell	111,233 -13,387	-11%	-$2.4M	0.56%	32
2019 Q1	$23.7M	Sell	124,620 -553	-0.4%	-$106K	0.63%	31
2018 Q4	$24.4M	Sell	125,173 -2,398	-2%	-$468K	0.76%	21
2018 Q3	$26.4M	Sell	127,571 -4,121	-3%	-$812K	0.67%	25
2018 Q2	$24.3M	Sell	131,692 -1,279	-1%	-$226K	0.66%	24
2018 Q1	$22.7M	Sell	132,971 -18,175	-12%	-$3.34M	0.58%	26
2017 Q4	$26.3M	Buy	151,146 +10,834	+8%	+$1.92M	0.68%	21
2017 Q3	$26.2M	Sell	140,312 -31,236	-18%	-$5.53M	0.7%	21
2017 Q2	$29.5M	Buy	171,548 +8,888	+5%	+$1.45M	0.81%	14
2017 Q1	$26.7M	Buy	162,660 +16,589	+11%	+$2.76M	0.76%	16
2016 Q4	$21.4M	Buy	146,071 +1,958	+1%	+$295K	0.62%	22
2016 Q3	$24M	Buy	144,113 +742	+0.5%	+$125K	0.7%	16
2016 Q2	$21.8M	Buy	143,371 +23,997	+20%	+$3.73M	0.65%	21
2016 Q1	$17.9M	Sell	119,374 -3,726	-3%	-$554K	0.54%	31
2015 Q4	$20M	Sell	123,100 -6,161	-5%	-$968K	0.59%	26
2015 Q3	$17.9M	Buy	129,261 +1,108	+0.9%	+$175K	0.54%	31
2015 Q2	$19.7M	Buy	128,153 +8,201	+7%	+$1.31M	0.55%	29
2015 Q1	$19.2M	Buy	119,952 +2,160	+2%	+$340K	0.52%	35
2014 Q4	$18.8M	Buy	117,792 +33,097	+39%	+$5.16M	0.54%	33
2014 Q3	$11.9M	Sell	84,695 -7,664	-8%	-$1M	0.35%	52
2014 Q2	$10.9M	Sell	92,359 -9,062	-9%	-$1.05M	0.33%	60
2014 Q1	$12.5M	Buy	101,421 +22,518	+29%	+$2.73M	0.38%	50
2013 Q4	$9M	Buy	78,903 +4,353	+6%	+$495K	0.29%	76
2013 Q3	$8.34M	Sell	74,550 -1,946	-3%	-$211K	0.29%	79
2013 Q2	$7.55M	Buy	+76,496	New	+$7.94M	0.29%	79

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Oppenheimer & Co's AMGN Position: Q2 2026 in Review

Oppenheimer & Co increased its Amgen (AMGN) stake by 2.8% in Q2 2026, buying an estimated $1.16M and bringing the position to 123,217 shares worth $44.6M. The position accounts for 0.48% of the portfolio, ranked #37.

Oppenheimer & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Oppenheimer & Co held 123,217 shares of Amgen worth $44.6M as of Q2 2026.
Oppenheimer & Co bought 3,376 Amgen shares in Q2 2026, an estimated $1.16M.
Amgen made up 0.48% of Oppenheimer & Co's portfolio in Q2 2026, its #37 holding.
Oppenheimer & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.